HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Takero Terayama Selected Research
Takero Terayama Research Topics
Disease
4
COVID-19
03/2023 - 01/2021
3
Respiratory Insufficiency (Respiratory Failure)
07/2022 - 12/2021
3
Sepsis (Septicemia)
08/2021 - 04/2017
3
Septic Shock (Toxic Shock Syndrome)
08/2021 - 04/2017
2
Wounds and Injuries (Trauma)
01/2024 - 01/2023
2
Infections
10/2023 - 03/2023
2
Bacterial Pneumonia
07/2022 - 07/2022
1
Shock
01/2024
1
Infertility (Sterility)
01/2024
1
Traumatic Brain Injuries (Traumatic Brain Injury)
12/2023
1
Invasive Candidiasis
10/2023
1
Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
07/2023
1
Acidosis
07/2023
1
Type 2 Diabetes Mellitus (MODY)
07/2023
1
Liddle Syndrome
01/2023
1
Alkalosis
01/2023
1
Malnutrition (Nutritional Deficiencies)
01/2023
1
Hypokalemia
01/2023
1
Edema (Dropsy)
12/2021
1
Hemorrhage
01/2020
1
Rupture
05/2019
1
Median Arcuate Ligament Syndrome
05/2019
1
Polyarteritis Nodosa (Periarteritis Nodosa)
05/2019
1
Aneurysm (Aneurysms)
05/2019
1
Colitis
01/2019
1
Pseudomembranous Enterocolitis (Pseudomembranous Colitis)
01/2019
1
Fever (Fevers)
01/2014
1
Suppuration
01/2014
Drug/Important Bio-Agent (IBA)
5
Oxygen (Dioxygen)
IBA
07/2022 - 01/2021
3
remdesivir
IBA
01/2022 - 01/2021
3
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2022 - 01/2021
3
favipiravir
IBA
01/2022 - 01/2021
3
tocilizumab (atlizumab)
FDA Link
01/2022 - 01/2021
3
Anticoagulants
IBA
01/2022 - 01/2021
2
Procalcitonin
IBA
07/2022 - 07/2022
2
C-Reactive Protein
IBA
07/2022 - 07/2022
2
Steroids
IBA
07/2022 - 07/2022
2
baricitinib
IBA
01/2022 - 01/2021
2
casirivimab and imdevimab drug combination
IBA
01/2022 - 01/2021
1
Follicle Stimulating Hormone (Follitropin)
FDA Link
01/2024
1
follitropin delta
IBA
01/2024
1
Antifungal Agents
IBA
10/2023
1
Sodium-Glucose Transporter 2 Inhibitors
IBA
07/2023
1
Blood Glucose (Blood Sugar)
IBA
07/2023
1
Sodium-Glucose Transport Proteins
IBA
07/2023
1
Hormones (Hormone)
IBA
01/2023
1
Mineralocorticoids
IBA
01/2023
1
Electrolytes
IBA
01/2023
1
nirmatrelvir and ritonavir drug combination
IBA
01/2022
1
molnupiravir
IBA
01/2022
1
sotrovimab
IBA
01/2022
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
12/2021
1
Hydroxychloroquine (Plaquenil)
FDA Link
Generic
01/2021
1
Carbon Dioxide
IBA
01/2020
1
purpurate-3,3'-diacetic acid
IBA
05/2019
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2019
1
Polymyxin B (Aerosporin)
FDA Link
Generic
04/2017
Therapy/Procedure
4
Therapeutics
07/2022 - 04/2017
4
Critical Care (Surgical Intensive Care)
08/2021 - 01/2021
3
Artificial Respiration (Mechanical Ventilation)
07/2022 - 01/2021
2
Positive-Pressure Respiration (Positive End-Expiratory Pressure)
07/2022 - 07/2022
2
Cannula
07/2022 - 07/2022
2
Extracorporeal Membrane Oxygenation
07/2022 - 07/2022
2
Respiratory Therapy (Therapy, Respiratory)
07/2022 - 07/2022
1
Thoracotomy
01/2024
1
Erythrocyte Transfusion
12/2023
1
Emergency Treatment
03/2023
1
Length of Stay
01/2023
1
Mechanical Ventilators (Ventilator)
01/2021
1
Conservative Treatment
01/2019
1
Hemoperfusion
04/2017
1
Catheters
01/2014